Response to recombinant human erythropoietin in patients with myelodysplastic syndromes

Clinical Cancer Research

Volumn 3, Issue 5, 1997, Pages 733-739

  Stasi, Roberto ^a   Brunetti, Maurizio ^a   Bussa, Stefano ^a   Conforti, Marina ^a   Di Giulio, Claudio ^a   Crescenzi, Anna ^a   Terzoli, Edmondo ^c   Vecchione, Aldo ^b   Pagano, Adalberto ^a  

^a REGINA APOSTOLORUM HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BURST FORMING UNIT; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEMATOPOIESIS; HEMOGLOBIN ANALYSIS; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RISK ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; BONE MARROW; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; TIME FACTORS;

EID: 0030958668     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Majani, H., Baines, P., Bowen, D. T., and Jacobs A. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia (Baltimore), 3: 29-32, 1989.
2. Jacobs, A., Janowska-Wieczorek, A., Caro, J., Bowen, D. J., and Lewis, T. Circulating erythropoietin in patients with myelodysplastic syndromes. Br. J. Haematol., 73: 36-39, 1989.
3. Rafanelli, D., Grossi, A., Longo, G., Vannucchi, A. M., Bacci, P., and Rossi-Ferrini, P. Recombinant human erythropoietin for treatment of myelodysplastic syndromes. Leukemia (Baltimore), 6: 323-327, 1992.
4. Aul, C., Arning, M., Runde, V., and Schneider, W. Serum erythropoietin concentrations in patients with myelodysplastic syndromes. Leuk. Res., 15: 571-575, 1991.
5. Legare, R. D., and Gilliland, D. G. Myelodysplastic syndrome. Curr. Opin. Hematol., 2: 283-292, 1995.
6. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R., and Sultan, C. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol., 51: 189-199, 1982.
7. Miller, A. B., Hoogstraten, B., Staquet, M., and Winkler, A. Reporting results of cancer treatment. Cancer (Phila.), 47: 207-214, 1981.
8. Stasi, R., Del Poeta, G., Masi, M., Tribalto, M., Venditti, A., Papa, G., Nicoletti, B., Vernole, P., Tedeschi, B., Delaroche, I., Mingarelli, R., and Dallapiccola, B. Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia. Cancer Genet. Cytogenet., 67: 28-34, 1993.
9. Iscove, N. N., Sieber, F., and Winterhalter, K. H. Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose concanavalin A. J. Cell Physiol., 83: 309-318, 1974.
10. Rose, E. H., Abels, R. I., Nelson, R. A., McCullough, D. M., and Lessin, L. The use of r-HuEpo in the treatment of anemia related to myelodysplasia (MDS). Br. J. Haematol., 89: 831-837, 1995.
11. Hellström-Lindberg, E. Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. Br. J. Haematol., 59: 67-71, 1995.
12. Isnard, F., Najman, A., Jaar, B., Fenaux, P., Baillou, C., Khoury, E., Labopin, M., Laporte, J. P., Woler, M., and Gorin N. C. Efficacy of recombinant human erythropoietin in the treatment of refractory anemias without excess of blasts in myelodysplastic syndromes. Leuk Lymphoma, 12: 307-314, 1994.
13. Depaoli, L., Levis, A., Isabella, N., Ficara, F., Priotto, C., Lista, P., Foà, R., and Resegotti L. Serum erythropoietin level and marrow erythroid infiltration predict response to recombinant human erythropoietin in myelodysplastic syndromes. Haematologica, 78: 118-122, 1993.
14. Bessho, M., Jinnai, I., Matsuda, A., Saito, M., and Hirashima, K. Improvement of anemia by recombinant human erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Int. J. Cell Cloning, 8: 445-458, 1990.
15. Van Kamp, H., Prinsze-Postema, T. C., Kluin, P. M., den Ottolander, G. J., Beverstock, G. C., Willemze, R., and Fibbe, W. E. Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia. Br. J. Haematol., 78: 488-493, 1991.
16. Verhoef, G. E. G., Zachee, P., Ferrant, A., Demuynck, H., Selleslag, D., Van Hove, L., Deckers, F., and Boogaerts, M. A. Recombinant human erythropoietin in patients with myelodysplastic syndrome: a clinical and erythrokinetic assessment. Ann. Hematol., 64: 16-21, 1992.
17. Ohio, R., Balleari, E., Ballestrero, A., Gatti, A. M., Mareni, C., Massa, G., Patrone, F., Sessarego, M., and Timitilli, S. Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. Acta Haematol., 90: 58-64, 1993.
18. Koury, M. J., and Bondurant, M. C. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science (Washington DC), 248: 378-380, 1990.
19. Kelley, L. L., Koury, M. J., Bondurant, M. C., Koury, S. T., Sawyer, S. T., and Wickrema, A. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood, 82: 2340-2352, 1993.
20. Aoki, I., Higashi, K., Homori, M., Chikazawa, H., and Ishikawa K. Responsiveness of bone marrow erythropoietic stem cells (CFU-E and BFU-E) to recombinant human erythropoietin in vitro in aplastic anemia and myelodysplastic syndrome. Am. J. Hematol., 35: 6-12, 1990.
21. Vadhan-Raj, S., Hittelman, W. N., Lepe-Zuniga, J. L., Gutterman, J. U., and Broxmeyer, H. E. Regulation of endogenous erythropoietin levels in anemia associated with myelodysplastic syndromes. Blood, 75: 1749-1750, 1990.
22. Stone, R. M., Bernstein, S. H., Demetri, G., Facklam, D. P., Arthur, K., Andersen, J., Aster, J. C., and Kufe, D. Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes. Leuk. Res., 18: 769-776, 1994.
23. Mittelman, M. Recombinant erythropoietin in myelodysplastic syndromes: whom to treat and how? More questions than answers. Acta Haematol, 90: 53-57, 1993.
24. Erslev, A. J. Erythropoietin. N. Engl. J. Med., 324: 1339-1344, 1991.